Drugs and the Criminal Justice System Coursework
Part A and Part B
PART A – Poster Plan
Harm Reduction and Drug Policy in the United Kingdom: Evaluating Criminal Justice
and Public Health Responses
Introduction and Context
Harm reduction has become one of the most debated contemporary issues within UK
drug policy and criminal justice. Harm reduction refers to policies and interventions
designed to minimise the negative social, physical and economic harms associated with
drug use without necessarily requiring abstinence (Marlatt, 1996). Examples include
needle exchange programmes, opioid substitution therapy, naloxone distribution and
safer drug consumption facilities.
The issue has become increasingly important in the United Kingdom due to rising drug-
related deaths, particularly in Scotland, which has one of the highest drug death rates in
Europe. Recent policy discussions have focused on whether drug use should be
approached primarily as a criminal justice issue or as a public health concern. Although
the UK continues to criminalise drug possession under the Misuse of Drugs Act 1971,
recent developments show a gradual shift towards harm reduction strategies.
The poster would critically evaluate harm reduction within the UK context by examining
criminological theory, current law and policy responses, debates within academic
literature and the impact on marginalised communities. The overall argument of the
poster would be that harm reduction presents a more effective and humane response to
problematic drug use than purely punitive criminal justice approaches.
Theoretical Perspectives Explaining the Relationship Between Drugs and Crime
The poster would primarily apply Labelling Theory to explain the relationship between
drugs, crime and criminal justice responses. Labelling theory, associated with Howard
Becker (1963), argues that deviance is socially constructed through the labels imposed by
society and state institutions. Individuals who are labelled as “drug offenders” may
internalise this identity, leading to exclusion, stigma and further criminalisation.
, This theory is particularly relevant to UK drug policy because criminalisation can
reinforce social marginalisation. Drug users frequently experience barriers to
employment, housing and healthcare due to criminal records and social stigma. Rather
than reducing harm, punitive drug policies may worsen social exclusion and increase
offending behaviour. Becker (1963) argued that societal reactions often create “secondary
deviance”, where individuals continue offending after being labelled deviant.
The poster would also briefly incorporate Critical Criminology and Social Harm Theory.
Critical criminologists argue that drug laws disproportionately target poorer and
marginalised communities while overlooking broader structural inequalities such as
poverty, homelessness and trauma (Taylor, Walton and Young, 1973). From this
perspective, the harms caused by criminalisation may exceed the harms caused by drug
use itself.
Current Law and Policy Responses
The poster would examine how UK drug policy remains heavily influenced by
criminalisation despite increasing support for harm reduction approaches. The principal
legislation governing controlled substances is the Misuse of Drugs Act 1971, which
classifies drugs into Classes A, B and C and criminalises possession, supply and
production offences.
Critics argue that the Act focuses excessively on punishment rather than public health
outcomes. Although intended to deter drug use, evidence suggests that criminalisation
has had limited success in reducing demand while contributing to prison overcrowding
and social exclusion (Eastwood, Fox and Rosmarin, 2016).
However, recent years have seen greater emphasis on harm reduction interventions.
Needle exchange programmes have become widely available across the UK to reduce the
transmission of blood-borne viruses such as HIV and hepatitis C. Naloxone programmes
have also expanded significantly, particularly in Scotland, where police officers and
pharmacies now routinely carry naloxone kits to prevent fatal opioid overdoses.
Another major development is the introduction of safer drug consumption facilities. In
2025, Glasgow opened the UK’s first officially sanctioned safer drug consumption
facility. The facility allows individuals to consume pre-obtained drugs under medical
supervision in hygienic conditions.
Academic Debates and Differing Viewpoints
A key section of the poster would evaluate competing viewpoints surrounding harm
Part A and Part B
PART A – Poster Plan
Harm Reduction and Drug Policy in the United Kingdom: Evaluating Criminal Justice
and Public Health Responses
Introduction and Context
Harm reduction has become one of the most debated contemporary issues within UK
drug policy and criminal justice. Harm reduction refers to policies and interventions
designed to minimise the negative social, physical and economic harms associated with
drug use without necessarily requiring abstinence (Marlatt, 1996). Examples include
needle exchange programmes, opioid substitution therapy, naloxone distribution and
safer drug consumption facilities.
The issue has become increasingly important in the United Kingdom due to rising drug-
related deaths, particularly in Scotland, which has one of the highest drug death rates in
Europe. Recent policy discussions have focused on whether drug use should be
approached primarily as a criminal justice issue or as a public health concern. Although
the UK continues to criminalise drug possession under the Misuse of Drugs Act 1971,
recent developments show a gradual shift towards harm reduction strategies.
The poster would critically evaluate harm reduction within the UK context by examining
criminological theory, current law and policy responses, debates within academic
literature and the impact on marginalised communities. The overall argument of the
poster would be that harm reduction presents a more effective and humane response to
problematic drug use than purely punitive criminal justice approaches.
Theoretical Perspectives Explaining the Relationship Between Drugs and Crime
The poster would primarily apply Labelling Theory to explain the relationship between
drugs, crime and criminal justice responses. Labelling theory, associated with Howard
Becker (1963), argues that deviance is socially constructed through the labels imposed by
society and state institutions. Individuals who are labelled as “drug offenders” may
internalise this identity, leading to exclusion, stigma and further criminalisation.
, This theory is particularly relevant to UK drug policy because criminalisation can
reinforce social marginalisation. Drug users frequently experience barriers to
employment, housing and healthcare due to criminal records and social stigma. Rather
than reducing harm, punitive drug policies may worsen social exclusion and increase
offending behaviour. Becker (1963) argued that societal reactions often create “secondary
deviance”, where individuals continue offending after being labelled deviant.
The poster would also briefly incorporate Critical Criminology and Social Harm Theory.
Critical criminologists argue that drug laws disproportionately target poorer and
marginalised communities while overlooking broader structural inequalities such as
poverty, homelessness and trauma (Taylor, Walton and Young, 1973). From this
perspective, the harms caused by criminalisation may exceed the harms caused by drug
use itself.
Current Law and Policy Responses
The poster would examine how UK drug policy remains heavily influenced by
criminalisation despite increasing support for harm reduction approaches. The principal
legislation governing controlled substances is the Misuse of Drugs Act 1971, which
classifies drugs into Classes A, B and C and criminalises possession, supply and
production offences.
Critics argue that the Act focuses excessively on punishment rather than public health
outcomes. Although intended to deter drug use, evidence suggests that criminalisation
has had limited success in reducing demand while contributing to prison overcrowding
and social exclusion (Eastwood, Fox and Rosmarin, 2016).
However, recent years have seen greater emphasis on harm reduction interventions.
Needle exchange programmes have become widely available across the UK to reduce the
transmission of blood-borne viruses such as HIV and hepatitis C. Naloxone programmes
have also expanded significantly, particularly in Scotland, where police officers and
pharmacies now routinely carry naloxone kits to prevent fatal opioid overdoses.
Another major development is the introduction of safer drug consumption facilities. In
2025, Glasgow opened the UK’s first officially sanctioned safer drug consumption
facility. The facility allows individuals to consume pre-obtained drugs under medical
supervision in hygienic conditions.
Academic Debates and Differing Viewpoints
A key section of the poster would evaluate competing viewpoints surrounding harm
